Pyridam Farma Tbk (PYFA)

Currency in IDR
550
-10(-1.79%)
Closed·
PYFA Scorecard
Full Analysis
Operates with a significant debt burden
PYFA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
535585
52 wk Range
136700
Key Statistics
Bid/Ask
550.00 / 555.00
Prev. Close
560
Open
560
Day's Range
535-585
52 wk Range
136-700
Volume
59.76M
Average Volume (3m)
105.81M
1-Year Change
115.38%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PYFA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Management has been aggressively buying back shares

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Pyridam Farma Tbk Company Profile

PT Pyridam Farma Tbk engages in the development, production, and trading of pharmaceuticals primarily in Indonesia. The company operates through Pharmaceutical Products, Esthetic, and Toll Manufacturing Services; and Medical Equipments segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper. The company also provides skin care products comprising Arosa gel, A-Stark Gel, Hymen gel, Pyderen Emulsion, Tonic Bust Emulsion, Calmosan Cream, and Di-Herb gel; medical support products; over the counter, ethical, and sigma products in the areas of musculo-skeletal, cardiovascular and hematopoietic system, genito urinary system, and respiratory system, as well as mineral and health supplements, vitamins, and other consumer health products in the form of syrups, tablets, and capsules; and sanitizers and antiseptics. PT Pyridam Farma Tbk was founded in 1976 and is based in Jakarta Selatan, Indonesia. PT Pyridam Farma Tbk operates as a subsidiary of Rejuve Global Investment Pte. Ltd.

Employees
1966
Market
Indonesia

Compare PYFA to Peers and Sector

Metrics to compare
PYFA
Peers
Sector
Relationship
P/E Ratio
−13.4x13.7x−0.7x
PEG Ratio
0.11−0.060.00
Price/Book
7.1x1.4x2.6x
Price / LTM Sales
2.1x1.0x3.4x
Upside (Analyst Target)
-21.4%35.7%
Fair Value Upside
Unlock16.9%4.1%Unlock

Earnings

Latest Release
Jul 31, 2025
EPS / Forecast
-12.14 / --
Revenue / Forecast
699.95B / --
EPS Revisions
Last 90 days

PYFA Income Statement

People Also Watch

1,425
EMTK
-4.04%
460
SCMA
+4.55%
4,110
BRPT
-0.72%
620
PSAB
+5.98%
1,140
ARCI
+10.14%

FAQ

What Stock Exchange Does Pyridam Farma Trade On?

Pyridam Farma is listed and trades on the Jakarta Stock Exchange stock exchange.

What Is the Stock Symbol for Pyridam Farma?

The stock symbol for Pyridam Farma is "PYFA."

What Is the Pyridam Farma Market Cap?

As of today, Pyridam Farma market cap is 6.18T.

What Is Pyridam Farma's Earnings Per Share (TTM)?

The Pyridam Farma EPS (TTM) is -55.29.

From a Technical Analysis Perspective, Is PYFA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Pyridam Farma Stock Split?

Pyridam Farma has split 2 times.

How Many Employees Does Pyridam Farma Have?

Pyridam Farma has 1966 employees.

What is the current trading status of Pyridam Farma (PYFA)?

As of 08 Oct 2025, Pyridam Farma (PYFA) is trading at a price of 550, with a previous close of 560.00. The stock has fluctuated within a day range of 535 to 585, while its 52-week range spans from 136 to 700.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.